Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GlaxoSmithKline plc

http://www.gsk.com

Latest From GlaxoSmithKline plc

Moderna Shone As COVID-19 Breakthroughs Were Rewarded At The 17th Annual Scrip Awards

The pharma, biotech and allied industries came back together in London on 2 December to celebrate a year of exceptional achievement at the 17th Annual Scrip Awards, hosted by the journalist and broadcaster Amol Rajan.

COVID-19 Treatment Xevudy Wins UK Approval; Preclinical Data Shows Promise Against Omicron

New developments on the COVID-19 front also include the European Medicines Agency starting a rolling review of Valneva’s investigational COVID-19 vaccine, and the UK government signing contracts with Pfizer/BioNTech and Moderna to buy more doses of their vaccines.

United Kingdom Coronavirus COVID-19

GSK Dives Into Neurology With £30m Oxford University Pact

After returning to the neuroscience space in the summer through a big-money deal with Alector, GlaxoSmithKline is setting up an institute with the University of Oxford that will target neurological diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, frontal temporal dementia, ALS and pain.

Deals Neurology

VBI Poised To Take On GSK, Dynavax As Hep B Vaccination Market Takes Off

VBI Vaccines obtained FDA approval of its three-antigen hepatitis B vaccine PreHevbrio and will take on GSK’s Engerix-B and Dynavax’s Heplisav-B as CDC recommends universal HBV immunization.

Approvals Vaccines
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Other Names / Subsidiaries
    • ABR Development
    • Cellzome
    • Corixa Corporation
    • Fountain Acquisition Corporation
    • Genelabs Technologies, Inc.
    • GlycoVaxyn AG
    • Human Genome Sciences, Inc.
    • ID Biomedical Corporation
    • Okairos AG
    • PRAECIS Pharmaceuticals, Inc.
    • Reliant Pharmaceuticals
    • Sirtris Pharmaceuticals
    • Sitari Pharmaceuticals, Inc.
    • SmithKline Beecham
    • Stiefel Laboratories, Inc.
    • Tesaro, Inc.
    • ViiV Healthcare
UsernamePublicRestriction

Register